Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
RRRobert RosensteinAHAugustus Hough
Summa Health System · Ludwig-Maximilians-Universität München
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
700
total citations
- FWCI
- 52.26
- Percentile
- 100%
- References
- 9
Citations per year
Authors
2- RRRobert RosensteinCorresponding
Summa Health System, Ludwig-Maximilians-Universität München
- AHAugustus Hough
Topics & keywords
Topics
Keywords
- Empagliflozin
- Medicine
- Type 2 diabetes
- Diabetes mellitus
- Benzhydryl compounds
- MEDLINE
- Internal medicine
- Intensive care medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.